News and Announcements
OncoSil Medical Presents at Asia BiotechInvest
- Published May 06, 2016 2:27PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4th May 2016, ASX Announcement
OncoDil Medical Limied (ASX: OSL) (OncoSil Medical or the Company) a late stage medical devices company focused on localised treatments for patients with pancreatic cancer and liver cancer, today announced that Chief Executive Officer, Daniel Kenny will present at the Asia Biotech Invest conference at the Hong Kong Convention Centre, Hong Kong on Thursday 5 May 2016.
The Asia Biotech Invest conference is hosted by AusBiotech as part of their Global Investment Event Series and runs from 5 to 6 May 2016 bringing together a number of institutional investors, partners and life sciences companies from across the Asia Pacific region. Mr Kenny and Chief Financial Officer, Tom Milicevic will also participate in one-on-one meetings with Asian investors during and prior to the conference.
To view the presentation, please click on the button below.